Drug Abuse Vulnerability: Mechanisms and Manifestations
药物滥用脆弱性:机制和表现
基本信息
- 批准号:8699322
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:12 year oldAdministratorAgeAlcohol or Other Drugs useAlcoholsApplications GrantsBasic ScienceBehaviorBiologicalBooksBudgetsCaffeineCannabisCategoriesCharacteristicsChildClinicalClinical EngineeringClinical ResearchCollaborationsConsumptionDSM-IVDataDaughterDevelopmentDiagnosticDisciplineDiseaseDoctor of MedicineDoctor of PhilosophyDrug abuseDrug usageEatingEducationEnrollmentEnsureEnvironmentEnvironmental Risk FactorEthicsEtiologyEvaluationEventExerciseExpenditureFacultyFamilyFamily memberFathersFrequenciesFundingGeneticGoalsGrantGuide preventionIllicit DrugsIndividualInterdisciplinary StudyInvestigationJournalsK-Series Research Career ProgramsLawsLeadershipLegalLinkLiteratureMaster of Public HealthMeasurementMental disordersMissionModelingMonitorMothersNIH Program AnnouncementsNamesNational Institute of Drug AbuseNational Institute of Neurological Disorders and StrokeNeurobiologyNursing FacultyOutcomePatternPharmaceutical PreparationsPilot ProjectsPoliciesPopulations at RiskPostdoctoral FellowPreventionProceduresProcessProtocols documentationProviderPsychological reinforcementPsychopathologyPublicationsRecommendationRecruitment ActivityResearchResearch InstituteResearch TrainingResourcesReview CommitteeRiskSafetyScienceServicesSeveritiesSonStagingStepparentStudentsSubstance Use DisorderSupervisionSystemTestingTimeTobaccoTrainingTraining and EducationTranslationsUnited States National Institutes of HealthVariantYouthaddictionarmbasebiobehaviordesigndidactic educationdrug abuse educationendophenotypeexperiencefollow-upfoothigh riskhuman diseaseillegal behaviorimplementation researchindexinginsightinstrumentationmenneurogeneticsnon-drugoffspringprobandprogramsprospectivepsychologicpublic health relevanceresponsesocial normstatisticstheoriestransmission process
项目摘要
DESCRIPTION (provided by applicant): This competing renewal application proposes to continue the follow-up research on 775 families enrolled in the Center's prospective investigations into the etiology of substance use disorder (SUD). The probands are men with lifetime presence/absence of SUD consequent to use of an illicit drug who have a 10-12 year old biological son or daughter. The biological children of SUD men are assigned to the high average risk (HAR) group whereas offspring of men without SUD, having neither axis 1 disorder ("normal") nor SUD psychiatric disorder, are assigned to the low average risk (LAR) groups. These children are currently in varying stages of follow-up evaluation conducted at ages 12-14, 16, 19, and annually thereafter until age 30. We have already shown that we can predict in 10-12 year old youth cannabis use disorder by age 22 with approximately 70% accuracy, thereby substantiating the paradigm, subject recruitment strategy and measurement protocols. Multidisciplinary research is conducted on family members (father, mother, children, step-parents) with the objective of elucidating the genetic, biobehavioral and environmental factors on development of SUD consequent to use of illegal drugs. Research protocols are organized into three thematically connected research modules (Neurogenetics. Developmental Psychopathology, and Translation) linking etiology and prevention. The research components thus align with the NIH Roadmap model such that basic science informs clinical research leading to prevention guided by an understanding of etiology. In addition to module-level research, faculty also participate in 3 centerwide aims: 1) Devise a practical scale to quantify the transmissible liability to SUD; 2) Empirically test a biopsychological theory of SUD etiology focusing on off time maturation leading to psychological dysregulation predisposing to SUD; and, 3) Delineate SUD liability variants within an ontogenetic framework. The Center has the program name Center for Education and Drug Abuse Research (CEDAR). It consists of six components (3 cores & 3 research modules): 1) Science Administration (R. Tarter, Ph.D.), 2) Clinical Core (J. Cornelius, M.D.), 3) Statistics Core (L. Kirisci, Ph.D.), 4) Neurogenetics Module (M. Vanyukov, Ph.D.) 5) Developmental Psychopathology Module (D. Clark, M.D., Ph.D.), and 6) Translation Module (Ty Ridenour, Ph.D.). Vertical and horizontal integration of the Center's components promote collaborative research encompassing multiple disciplines. To date, this research program has supported over 360 publications, 4 books, and 3 special journal issues as well as the training of numerous students, faculty and fellows. Six K awards are currently funded using CEDAR resources.
描述(由申请人提供):这种竞争性更新申请建议继续对该中心对物质使用障碍病因的前瞻性调查的775个家庭进行的后续研究(SUD)。这些概率是男性,终生存在/缺乏SUD,因此使用具有10至12岁的亲生儿子或女儿的非法药物。 SUD男性的生物儿童被分配到高平均风险(HAR)组,而没有SUD的男性的后代,既没有轴1障碍(“正常”)和SUD精神病障碍,被分配到低平均风险(LAR)组。这些孩子目前处于在12-14、16、19、19、19岁和此后每年进行的随访评估的不同阶段。我们已经表明,我们可以预测到22岁的10-12岁青年大麻使用障碍,其准确性约为70%,从而实现了范式,招募策略和测量策略和测量协议。 多学科研究是针对家庭成员(父亲,母亲,儿童,继父母)进行的,目的是阐明遗传,生物行为和环境因素,用于使用非法药物的SUD的发展。研究方案分为三个主题联系的研究模块(神经遗传学,发育心理病理学和翻译),将病因和预防联系起来。因此,研究组件与NIH路线图模型保持一致,因此基础科学会为临床研究提供信息,从而导致对病因的理解为指导。 除了模块级研究外,教师还参与了3个核心目标:1)设计一个实用量表来量化对SUD的可传染性责任; 2)从经验上测试SUD病因的生物心理学理论,重点是时间成熟,导致心理失调障碍易于SUD; 3)在一个遗传框架内描述SUD责任变体。 该中心设有教育和药物滥用研究中心(CEDAR)。它由六个组成部分(3个核心和3个研究模块)组成:1)科学管理(R. Tarter,Ph.D.),2)临床核心(J. Cornelius,M.D。),3)统计核心(L. Kirisci,Ph.D. 6)翻译模块(Ty Ridenour,博士)。 该中心组件的垂直和水平整合促进了包括多个学科的协作研究。迄今为止,该研究计划已支持360多个出版物,4本书和3个特殊期刊问题,以及对众多学生,教职员工和研究员的培训。目前使用Cedar Resources资助六个K奖项。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RALPH E TARTER其他文献
RALPH E TARTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RALPH E TARTER', 18)}}的其他基金
ALEXSA Adaptation for Use in Large Scale Substance Use Surveys
ALEXSA 适用于大规模药物使用调查
- 批准号:
7304876 - 财政年份:2008
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Full participation of people with physical disabilities in active eSports
身体残疾人士充分参与活跃的电子竞技
- 批准号:
10646057 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
通过扩大姑息治疗的范围来应对 COVID-19 的挑战:为老年人和所有痴呆症患者提供视频的主动预先护理计划
- 批准号:
10784057 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Mindfulness Intervention for College Students with ADHD
多动症大学生的正念干预
- 批准号:
10730772 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Integrating the Youth Nominated Support Team (YST) with CBT for Black Youth with Acute Suicide Risk
将青年提名支持团队 (YST) 与针对有急性自杀风险的黑人青年的 CBT 相结合
- 批准号:
10573542 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别: